Tumor-Targeted and Biocompatible MoSe2 Nanodots@Albumin Nanospheres as a Dual-Modality Therapy Agent for Synergistic Photothermal Radiotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-Targeted and Biocompatible MoSe2 Nanodots@Albumin Nanospheres as a Dual-Modality Therapy Agent for Synergistic Photothermal Radiotherapy
Authors
Keywords
MoSe<sub>2</sub>, Biocompatibility, Photothermal therapy, Radiotherapy, Dual-modality therapy
Journal
Nanoscale Research Letters
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-26
DOI
10.1186/s11671-019-2896-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tumor targeted, stealthy and degradable bismuth nanoparticles for enhanced X-ray radiation therapy of breast cancer
- (2018) Junjie Deng et al. BIOMATERIALS
- Surface-bioengineered Gold Nanoparticles for Biomedical Applications
- (2018) Zhicong Miao et al. CURRENT MEDICINAL CHEMISTRY
- Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo
- (2018) Wentao Deng et al. International Journal of Nanomedicine
- PEG-copolymer-coated iron oxide nanoparticles that avoid the reticuloendothelial system and act as kidney MRI contrast agents
- (2018) Vanessa Gómez-Vallejo et al. Nanoscale
- Hybrid MoSe2–indocyanine green nanosheets as a highly efficient phototheranostic agent for photoacoustic imaging guided photothermal cancer therapy
- (2018) Jingqin Chen et al. Biomaterials Science
- Co-administration of biocompatible self-assembled polylactic acid–hyaluronic acid block copolymer nanoparticles with tumor-penetrating peptide-iRGD for metastatic breast cancer therapy
- (2018) Caifeng Deng et al. Journal of Materials Chemistry B
- 2D transition metal dichalcogenide nanosheets for photo/thermo-based tumor imaging and therapy
- (2018) Hang Chen et al. Nanoscale Horizons
- Artesunate-Loaded and Near-Infrared Dye-Conjugated Albumin Nanoparticles as High-Efficiency Tumor-Targeted Photo-Chemo Theranostic Agent
- (2018) Hainan Yang et al. Nanoscale Research Letters
- Reduced graphene oxide (rGO) hybridized hydrogel as a near-infrared (NIR)/pH dual-responsive platform for combined chemo-photothermal therapy
- (2018) Wei Liu et al. JOURNAL OF COLLOID AND INTERFACE SCIENCE
- Resveratrol-Loaded Albumin Nanoparticles with Prolonged Blood Circulation and Improved Biocompatibility for Highly Effective Targeted Pancreatic Tumor Therapy
- (2017) Tao Geng et al. Nanoscale Research Letters
- Resveratrol-Loaded Albumin Nanoparticles with Prolonged Blood Circulation and Improved Biocompatibility for Highly Effective Targeted Pancreatic Tumor Therapy
- (2017) Tao Geng et al. Nanoscale Research Letters
- Comprehensive track-structure based evaluation of DNA damage by light ions from radiotherapy-relevant energies down to stopping
- (2017) W. Friedland et al. Scientific Reports
- MoS2 Quantum Dot@Polyaniline Inorganic–Organic Nanohybrids for in Vivo Dual-Modal Imaging Guided Synergistic Photothermal/Radiation Therapy
- (2016) Jinping Wang et al. ACS Applied Materials & Interfaces
- Perfluorocarbon-Loaded Hollow Bi2Se3Nanoparticles for Timely Supply of Oxygen under Near-Infrared Light to Enhance the Radiotherapy of Cancer
- (2016) Guosheng Song et al. ADVANCED MATERIALS
- Cancer treatment and survivorship statistics, 2016
- (2016) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Radiotherapy for Non-Small Cell Lung Cancer Induces DNA Damage Response in Both Irradiated and Out-of-field Normal Tissues
- (2016) S. Siva et al. CLINICAL CANCER RESEARCH
- Aqueous phase preparation of ultrasmall MoSe2 nanodots for efficient photothermal therapy of cancer cells
- (2016) Lihui Yuwen et al. Nanoscale
- Bottom-Up Synthesis of Metal-Ion-Doped WS2 Nanoflakes for Cancer Theranostics
- (2015) Liang Cheng et al. ACS Nano
- The DNA Damage Response: Implications for Tumor Responses to Radiation and Chemotherapy
- (2015) Michael Goldstein et al. Annual Review of Medicine
- Radionuclide 131I labeled reduced graphene oxide for nuclear imaging guided combined radio- and photothermal therapy of cancer
- (2015) Lei Chen et al. BIOMATERIALS
- Anti-PEG IgM Is a Major Contributor to the Accelerated Blood Clearance of Polyethylene Glycol-Conjugated Protein
- (2015) Yu Mima et al. MOLECULAR PHARMACEUTICS
- In vivo biodistribution and clearance of peptide amphiphile micelles
- (2015) Eun Ji Chung et al. Nanomedicine-Nanotechnology Biology and Medicine
- Recent advances in the fabrication and structure-specific applications of graphene-based inorganic hybrid membranes
- (2015) Xinne Zhao et al. Nanoscale
- Multiple facets of histone variant H2AX: a DNA double-strand-break marker with several biological functions
- (2015) Valentina Turinetto et al. NUCLEIC ACIDS RESEARCH
- Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
- (2015) Gaia Schiavon et al. Science Translational Medicine
- One-step reduction and PEGylation of graphene oxide for photothermally controlled drug delivery
- (2014) Jingqin Chen et al. BIOMATERIALS
- Sub-100nm gold nanomatryoshkas improve photo-thermal therapy efficacy in large and highly aggressive triple negative breast tumors
- (2014) Ciceron Ayala-Orozco et al. JOURNAL OF CONTROLLED RELEASE
- Size-dependent internalisation of folate-decorated nanoparticles via the pathways of clathrin and caveolae-mediated endocytosis in ARPE-19 cells
- (2013) Wai-Leung Langston Suen et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Ultrasmall Reduced Graphene Oxide with High Near-Infrared Absorbance for Photothermal Therapy
- (2011) Joshua T. Robinson et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More